Common Contracts
1 similar Clinical Trial Agreement contracts
ContractClinical Trial Agreement • March 2nd, 2018
Amendment # 1 to CLINICAL TRIAL AGREEMENT Protocol No. GED-0301-CD-002 Dodatek č. 1 ke SMLOUVĚ O KLINICKÉ STUDII Protokol č. GED-0301-CD-002 This amendment (“Amendment”) is made by Tento dodatek („Dodatek“) je uzavřen mezi Celgene Corporation, having its principal office at 86 Morris Avenue, Summit, NJ 07901, USA (“Sponsor”) represented by Celgene International Sàrl., a limited liability company organized under the laws of Switzerland having its principal office at Route de Perreux 1, 2017 Boudry, Switzerland.For the only purposes of signing this Amendment Sponsor is represented by Quintiles Czech Republic s.r.o., having a place of business at Radlicka 714/113a,158 00 Praha 5, Czech Republic, Identification number: 247 68 651, Tax identification number: CZ247 68 651 (“IQVIA”). Celgene Corporation, se sídlem 86 Morris Avenue, Summit, New Jersey 07901, USA („Zadavatel”), zastoupenou společností Celgene International S.à.r.l, společností s ručením omezeným založenou podle právního řádu Šv
